Cellex Incorporated | 439 followers on LinkedIn | Covid-19 | Rapid Test Approved by FDA for EUA Use | Cellex qSARS-CoV-2 IgG/IgM Rapid Test | Founded in 2002, Cellex Incorporated is a biotechnology company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly at point-of-care (POC) settings. On April 1, 2020, Cellex was the first company to receive the Emergency Use Authorization (EUA) for the COVID-19 serology test by the FDA for the qSARS-CoV-2 IgG/IgM Rapid Test. The corporate headquarters are located in Research Triangle Park, North Carolina.
Looking for a particular Cellex Incorporated employee's phone or email?
Cellex Incorporated Questions
The Cellex Incorporated annual revenue was $1 million in 2026.
4 people are employed at Cellex Incorporated.
Cellex Incorporated is based in Durham, North Carolina.
The NAICS codes for Cellex Incorporated are [541713, 54, 5417, 54171, 541].
The SIC codes for Cellex Incorporated are [873, 87].
Related Companies
